Dr. Xiao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Avenue
New York, NY 10065
Summary
- Dr. Wenbin Xiao is a pathologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from Peking University and has been in practice 14 years. He specializes in hematopathology, anatomic pathology, and clinical pathology and is experienced in leukemia and lymphoma.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematopathology, 2014 - 2016
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 2010 - 2014
- Beijing Medical UniversityClass of 2003, MD
Certifications & Licensure
- NJ State Medical License 2021 - 2025
- NY State Medical License 2016 - 2025
- PA State Medical License 2013 - 2016
- OH State Medical License 2010 - 2014
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Hematology
Publications & Presentations
PubMed
- In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy.Robert L Bowman, Andrew J Dunbar, Tanmay Mishra, Wenbin Xiao, Michael R Waarts
Cancer Cell. 2024-11-11 - 1 citationsCRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2- and TET2-mutant Cells.Michael R Waarts, Shoron Mowla, Meaghan Boileau, Anthony R Martinez Benitez, Junya Sango
Cancer Discovery. 2024-10-04 - 1 citationsCell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies.Melissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, Mark D Ewalt, JinJuan Yao
Haematologica. 2024-10-01
Abstracts/Posters
- A Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL / SLLA Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or R...Jennifer R Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute LeukemiaWenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Stag2 Regulates Hematopoietic Differentiation and Self-Renewal through Alterations in Gene Expression and Topological ControlWenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Mission Bio Launches Single-Cell MRD Assay for Blood Cancer PatientsSeptember 28th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: